Unilever is acquiring US health supplement brand Grüns, while American Pacific Group has invested in fragrance house Dossier. Indian beauty retailer Nykaa is reportedly in talks to buy a majority stake in Deepika Padukone’s 82°E. These moves signal a continued industry trend where larger entities absorb or partner with businesses focused on health-adjacent wellness products and niche fragrance markets. For UK salon and barbershop owners, this suggests a growing emphasis on holistic beauty and the potential for new product lines or treatments emerging from these consolidated portfolios.
Amway reported global revenue of US$7.3 billion, with growth in its ESAN region. K-beauty exports hit a record US$3.1 billion in the first quarter. Nykaa anticipates its fastest quarterly revenue growth in three years. These figures highlight regional economic strengths and export success, particularly for Korean beauty brands. Salon owners focusing on specific international beauty trends might find inspiration or new import opportunities emerging from these high-growth markets.
La Roche-Posay is rolling out nationwide in Walmart stores. Amazon has secured a deal with USPS for over one billion annual package deliveries. Meanwhile, Saks Global has obtained US$500 million in financing for restructuring, and Give Me Cosmetics has entered administration. This mixed picture shows established brands leveraging major retail channels and logistics while some companies struggle with financial pressures. The administration of Give Me Cosmetics, in particular, serves as a reminder of the challenges in maintaining profitability even with significant retail presence.
P&G issued a warning to shareholders about a discounted mini-tender offer, and Tom’s of Maine agreed to a US$2.9 million settlement regarding toothpaste claims. UK regulators are investigating peptide clinics for unlawful health claims. These legal and regulatory actions demonstrate ongoing scrutiny of marketing practices and product claims. Businesses offering treatments that blur the lines between beauty and health, especially those involving peptides or innovative ingredients, must ensure absolute compliance with UK advertising and medical guidance.
